Invesco Amends Zai Lab Stake, Signals Portfolio Adjustment
Ticker: ZLAB · Form: SC 13G/A · Filed: Feb 1, 2024 · CIK: 1704292
| Field | Detail |
|---|---|
| Company | Zai Lab Ltd (ZLAB) |
| Form Type | SC 13G/A |
| Filed Date | Feb 1, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Invesco just updated its Zai Lab holdings, watch for market reaction.**
AI Summary
Invesco Ltd. filed an amended SC 13G/A on February 1, 2024, indicating a change in their ownership of Zai Lab Ltd. common stock and ADRs as of December 29, 2023. This filing, Amendment No. 2, updates their previous disclosures regarding their passive investment in the pharmaceutical company. This matters to investors because Invesco is a major institutional investor, and changes in their holdings can signal shifts in their confidence or strategy regarding Zai Lab Ltd.'s future prospects.
Why It Matters
Changes in significant institutional holdings can influence market sentiment and potentially impact Zai Lab Ltd.'s stock price, as other investors may follow the lead of large funds like Invesco.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate, significant risk to the company.
Analyst Insight
Investors should monitor Zai Lab Ltd.'s stock performance and any subsequent filings from Invesco Ltd. or other major institutional investors to understand the broader sentiment and potential impact on the stock.
Key Players & Entities
- Invesco Ltd. (company) — the reporting person and institutional investor
- Zai Lab Ltd. (company) — the subject company whose securities are being reported
- December 29, 2023 (date) — the date of the event requiring the filing
- February 1, 2024 (date) — the filing date of the SC 13G/A
- G9887T116 (other) — the CUSIP number for Zai Lab Ltd. securities
FAQ
What type of filing is this document and what does it generally indicate?
This document is an SC 13G/A, which is an amendment to a Schedule 13G. It generally indicates that an institutional investor, like Invesco Ltd., has updated its passive ownership stake in a company, Zai Lab Ltd., and is not seeking to influence management.
Who is the reporting person in this SC 13G/A filing?
The reporting person in this SC 13G/A filing is Invesco Ltd., an investment advice company with a Central Index Key (CIK) of 0000914208.
What is the subject company whose securities are being reported on?
The subject company is Zai Lab Ltd., a pharmaceutical preparations company with a Central Index Key (CIK) of 0001704292. The securities are Common Stock and ADR.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, as stated on the cover page of the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Stats: 994 words · 4 min read · ~3 pages · Grade level 7.5 · Accepted 2024-02-01 16:00:13
Filing Documents
- SEC13G_Filing.htm (SC 13G/A) — 16KB
- 0000914208-24-000055.txt ( ) — 18KB
From the Filing
SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 ) * Zai Lab Ltd (Name of Issuer) Common Stock and ADR (Title of Class of Securities) G9887T116 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. G9887T116 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Invesco Ltd. 98-0557567 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 19,070,718 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 19,070,718 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 19,070,718 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.9% 12. TYPE OF REPORTING PERSON HC, IA Item 1. (a) Name of Issuer Zai Lab Ltd (b) Address of Issuer's Principal Executive Offices 4560 Jinke Road, Building 1, 4th Floor, Jinchuang Plaza, Pudong, Shanghai 201210, CN Item 2. (a) Name of Person Filing Invesco Ltd. ("Invesco Ltd.") (b) Address of Principal Business Office or, if None, Residence 1331 Spring Street NW, Suite 2500, Atlanta, GA 30309 (c) Citizenship Bermuda (d) Title of Class of Securities Common Stock and ADR (e) CUSIP Number G9887T116 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J). Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: Invesco Ltd. , in its capacity as a parent holding company to its investment advisers, may be deemed to beneficially own 19,070,718 shares of the Issuer which are held of record by clients of Invesco Ltd. . (b) Percent of Class: 1.9% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 19,070,718 (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 19,070,718 (iv) shared power to dispose or to direct the disposition of 0 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ X ] Item 6. However, no one individual has greater than 5% economic ownership. The shareholders of the Fund have the right to receive or the power to direct the receipt of dividends and proceeds from the sale of securities listed above. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Invesco Advisers, Inc. Invesco Capital Management LLC Item 8. Identification and Classification of Members of the Group. Not Applicable. This schedule